Stanford Medicine Catalyst is a joint strategic effort between Stanford’s School of Medicine, Stanford Health Care, and Stanford Children’s Health, and serves as Stanford Medicine’s flagship innovation program to support inventors across the Stanford community in developing and accelerating their most promising innovations for transformative health.

Catalyst supports impactful, prototype-stage innovations across the spectrum of healthcare, with a focus on Digital Health, Medical Technology, Diagnostics, and Therapeutics. Catalyst fosters these innovations by offering up to $1M in capital, mentorship and access to industry experts. Chosen projects also receive program management, validation resources, testing and deployment within a regional health care system, go-to-market resources, readiness for independence and exposure to outside investors.

As a preeminent hotbed of transformative healthcare innovations, situated in the heart of Silicon Valley, Stanford holds limitless potential–and Catalyst exists to help navigate the challenges of successful and rapid translation of these great ideas, and scaling them to the broader patient population. We’re excited about the role Stanford Medicine Catalyst can serve in helping to realize this potential.

Still have questions? Visit our FAQ page, or contact us.